Cite
Pretargeting for imaging and therapy in oncological nuclear medicine.
MLA
Bailly, Clément, et al. “Pretargeting for Imaging and Therapy in Oncological Nuclear Medicine.” EJNMMI Radiopharmacy & Chemistry, vol. 2, no. 1, June 2017, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s41181-017-0026-8.
APA
Bailly, C., Bodet-Milin, C., Rousseau, C., Faivre-Chauvet, A., Kraeber-Bodéré, F., & Barbet, J. (2017). Pretargeting for imaging and therapy in oncological nuclear medicine. EJNMMI Radiopharmacy & Chemistry, 2(1), 1–14. https://doi.org/10.1186/s41181-017-0026-8
Chicago
Bailly, Clément, Caroline Bodet-Milin, Caroline Rousseau, Alain Faivre-Chauvet, Françoise Kraeber-Bodéré, and Jacques Barbet. 2017. “Pretargeting for Imaging and Therapy in Oncological Nuclear Medicine.” EJNMMI Radiopharmacy & Chemistry 2 (1): 1–14. doi:10.1186/s41181-017-0026-8.